Sources

12 Total Sources

Rasonque Access Gap Forces $9,286 Purchase as FDA Approval Closes Early-Use Path

Pancreatic Cancer Drug Rasonque: Patient Struggles for Access Post-FDA Approval

philstockworld.com3d ago

Revolution Medicines' Daraxonrasib Wins FDA Approval as Rasonque: What the RAS Breakthrough Means for RVMD Investors - Phil Stock World

Healthcare Brew3d ago

Oncologists say newly approved pancreatic cancer drug is a breakthrough for treatment

PanCAN on X: "A RAS inhibitor called Rasonque™ (daraxonrasib) is approved for the treatment of adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or are not

Oncodaily2d ago

David Gandara: Daraxonrasib Marks a Major Advance in Pancreatic Cancer Care - OncoDaily

The Washington Post3d ago

FDA approves 'landmark' pancreatic cancer drug daraxonrasib - The Washington Post

FDA approves daraxonrasib, a new treatment for advanced pancreatic cancer

Daraxonrasib approved for metastatic pancreatic adenocarcinoma

Trump's cuts threaten access to a life-saving pancreatic cancer drug

FDA Approves Daraxonrasib for Pancreatic Cancer | Yüksel ÜRÜN posted on the topic | LinkedIn

Instagram3d ago

A newly approved pancreatic cancer pill has shown extraordinary promise in treating lung cancer — shrinking tumors in more than a third of patients during clinical trials. In a major medical development,

South Florida Sun Sentinel3d ago

Florida patients see promising results with new cancer drug